Genpact Limited has revised its FY23 outlook, now expecting total revenue in the range of $4.59 billion to $4.64 billion, up 5.0% to 6.0% year-over-year, compared to the prior full-year outlook in the range of $4.64 billion to $4.71 billion. Adjusted diluted EPS is expected to be in the range of $2.91 to $2.94, compared to the prior range of $2.92 to $2.99. The company continues to expect an adjusted income from operations margin of approximately 16.8%.